Loading...
Receive $200 for creating an Interactive Brokers account using our link: Create IBKR account. Read our Interactive Brokers analysis
- Ticker
- LSTA
- Price
- 4.56
- Stock movement down
- -0.01 (-0.22%)
- Company name
- Lisata Therapeutics Inc.
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Biotechnology
- Market cap
- 40.22M
- Ent value
- 25.86M
- Price/Sales
- 37.59
- Price/Book
- 2.35
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- 5.05%
- 1 year return (CAGR)
- 74.05%
- 3 year return (CAGR)
- 10.83%
- 5 year return (CAGR)
- -33.28%
- 10 year return (CAGR)
- -24.57%
Last updated: 2026-02-20
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
DIVIDENDS
LSTA does not pay dividends or no data was received
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 37.59 |
| Price to Book | 2.35 |
| EV to Sales | 24.17 |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 8.82M |
| EPS (TTM) | -2.09 |
| FCF per share (TTM) | -1.98 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 1.07M |
| Gross profit (TTM) | 1.03M |
| Operating income (TTM) | -20.08M |
| Net income (TTM) | -18.24M |
| EPS (TTM) | -2.09 |
| EPS (1y forward) | -1.02 |
Margins
Loading...
Margins data
| Gross margin (TTM) | 95.98% |
| Operating margin (TTM) | -1876.45% |
| Profit margin (TTM) | -1704.86% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 19.00M |
| Net receivables | 1.20M |
| Total current assets | 21.57M |
| Goodwill | 0.00 |
| Intangible assets | 139.00K |
| Property, plant and equipment | 494.00K |
| Total assets | 21.76M |
| Accounts payable | 619.00K |
| Short/Current long term debt | 0.00 |
| Total current liabilities | 4.57M |
| Total liabilities | 4.64M |
| Shareholder's equity | 17.12M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -17.23M |
| Capital expenditures (TTM) | 56.00K |
| Free cash flow (TTM) | -17.28M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -106.56% |
| Return on Assets | -83.84% |
| Return on Invested Capital | -106.56% |
| Cash Return on Invested Capital | -100.96% |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 4.55 |
| Daily high | 4.59 |
| Daily low | 4.55 |
| Daily Volume | 36K |
| All-time high | 18187500.00 |
| 1y analyst estimate | 11.33 |
| Beta | 1.27 |
| EPS (TTM) | -2.09 |
| Dividend per share | 0.00 |
| Ex-div date | 28 Oct 2013 |
| Next earnings date | 26 Feb 2026 |
Downside potential
Loading...
Downside potential data
| LSTA | S&P500 | |
| Current price drop from All-time high | -100.00% | -1.82% |
| Highest price drop | -100.00% | -56.47% |
| Date of highest drop | 17 Feb 2026 | 9 Mar 2009 |
| Avg drop from high | -94.52% | -10.84% |
| Avg time to new high | 536 days | 12 days |
| Max time to new high | 7527 days | 1805 days |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
COMPANY DETAILS
Marketcap
40.22M
Marketcap category
Small-cap
Description
Lisata Therapeutics, Inc., a clinical-stage pharmaceutical company, engages in the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product is certepetide, which is in Phase 2 clinical studies for the treatment of solid tumors, such as metastatic pancreatic ductal adenocarcinoma, cholangiocarcinoma, appendiceal cancer, and colon cancer and glioblastoma multiforme in combination with a range of anti-cancer regimens. The company was incorporated in 1980 and is headquartered in Basking Ridge, New Jersey.
Employees
26
Website
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
iO Charts is a Seeking Alpha partnerNext page